On July 21, 2026, Novo Nordisk filed a federal lawsuit against Eli Lilly in the United States District Court for the District of New Jersey, accusing its rival of running nationwide advertising that misleads the public about the comparative efficacy of blockbuster GLP-1 medicines. The complaint marks a dramatic escalation in the fight between the More